Rheumatoid Arthritis
Contact Summit Research
Study Qualification
Note: We will respond to your email within 2 business days. If you have not received a response within that time, please check the spam folder in your email program. All information you provide is stored in a secure site, and cannot be released to any third party without your written and signed authorization.
Our Process
What Will I Be Asked To Do
As part of the MARASLE clinical trial, you will attend prescheduled appointments (study visits).
You will attend a screening visit to check if you qualify for the trial, and if you do, at your next appointment you will be randomly assigned to receive the investigational study drug or placebo and will enter the study.
At most visits the study team will ask you questions about your condition. You will be asked to provide accurate information about your medical history, other medications you are taking, and other medical conditions you may have. Your clinician will also be checking on your Rheumatoid Arthritis at every visit.
Your care team will check your general health at the majority of your visits. You will be asked to give blood and urine samples during your study visits, and will also be asked to complete a number of questionnaires during your visits.
This trial will test the investigational drug's safety and tolerability, which is currently unknown. And this is where you'll come in to help!
For more information, please speak to your participating site study doctor or study staff.
A description of this study can also be found on the website www.ClinicalTrials.gov
by searching for NCT06031415.
Are You Living With Rheumatoid Arthritis?
YOU MAY BE A CANDIDATE FOR THE MARASLE CLINICAL TRIAL.
MARASLE Clinical Trial
If you’re an adult living with Rheumatoid Arthritis, you may be a candidate for the MARASLE Clinical Trial.
The goal of this trial is to evaluate whether an injection of an investigational drug is safe and tolerable in participants like you who have Rheumatoid Arthritis. We are also reviewing whether the investigational drug may improve your Rheumatoid Arthritis.
Participating in this clinical trial means you are helping researchers determine if the investigational drug is safe for use.
Who Would Qualify for This Trial?
The MARASLE Clinical Trial is looking for participants who*:
Are between the ages of 18 and 75
Have been diagnosed with moderate to severe Rheumatoid Arthritis
*Please note that these are high-level qualification criteria. Additional criteria will be discussed when you meet with the study team.
What Is Involved In The Marasle Clinical Trial?
Trial Design
The MARASLE Clinical Trial is a 28-week trial in which you would visit the clinic at least 15 times. A screening visit is required up to 29 days prior to determine if you are willing, able, and eligible to participate.
Investigational Study Drug
As part of the MARASLE Clinical Trial, you will be randomly chosen to receive either the investigational study drug or a placebo for 12 weeks. You will have a 2-out-of-3 chance of receiving the investigational study drug. You will be given an in-clinic injection every 2 weeks.
After you have finished taking the investigational study drug or placebo, you will have follow-up visits.
Care
As a study participant, your study team will check your general health and assess your Rheumatoid Arthritis.
You will receive compensation for the time taken to complete the study visits. You will also be reimbursed for any reasonable travel expenses (bus, train, taxi fares, and gas) you incur while attending your study visits.
The investigational study drug and all lab tests and procedures that are part of this study will be provided at no cost to you.
Frequently Asked Questions
WHAT ARE CLINICAL TRIALS?
Trials such as this evaluate a new treatment or therapy in healthy volunteers or in patients with a specific illness or condition, such as yourself.
An investigational drug means that the United States Food and Drug Administration (FDA) has not approved it for use as a prescription medicine. However, the government health authority has given permission to test this drug in Rheumatoid Arthritis patients, and it has already been tested in healthy volunteers and in patients with RA.
Clinical trials are performed according to government regulations, which help protect your safety and rights.
Trials are designed to ensure your condition is closely monitored during the trial for any changes, including any potential side effects of the study drug.
The investigational drug can be temporarily or permanently stopped by your study doctor.
Participation is completely voluntary. If you decide to participate, you can choose to leave the trial at any time.
Quality care at no cost
At Summit Research Network, our diabetes research studies are provided at no cost to those who qualify. No health insurance is required. Our studies are led by board-certified physicians who have conducted hundreds clinical trials. Your comfort and safety is their number one concern.
